The Conundrum of Online Prescription Drug Promotion: Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"

This commentary discusses pertinent issues from Hyosun Kim’s paper on online prescription drug promotion. The study is well-designed and the findings highlight some of the consequences of the Food and Drug Administration’s (FDA’s) decision to deregulate online advertising of prescription drugs. Whil...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Health Policy Manag
Autor principal: Wanasika, Isaac
Format: Artigo
Idioma:Inglês
Publicat: Kerman University of Medical Sciences 2016
Matèries:
Commentary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4885732/
https://ncbi.nlm.nih.gov/pubmed/27285519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/ijhpm.2016.33
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars